THURSDAY, April 28 (HealthDay News) -- Use of a costly breast
cancer therapy called intensity-modulated radiation therapy is strongly
influenced by what Medicare will pay for the treatment and where radiation
oncologists practice, according to a new study.
Researchers analyzed Medicare data for 26,163 women with localized
breast cancer who had surgery and radiation therapy between 2001 and 2005.
During that time, Medicare billing for the treatment, called
No comments:
Post a Comment